Search Results - "Zou, Fenfei"

Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer by Sugano, Teppei, Seike, Masahiro, Noro, Rintaro, Soeno, Chie, Chiba, Mika, Zou, Fenfei, Nakamichi, Shinji, Nishijima, Nobuhiko, Matsumoto, Masaru, Miyanaga, Akihiko, Kubota, Kaoru, Gemma, Akihiko

“…Patients with non-small cell lung cancer (NSCLC) EGFR mutations have shown a dramatic response to EGFR inhibitors (EGFR-TKI). EGFR T790M mutation and MET…”
Get full text

Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective study by Nakamichi, Shinji, Kubota, Kaoru, Zou, Fenfei, Hayashi, Anna, Takano, Natsuki, Onda, Naomi, Matsumoto, Masaru, Miyanaga, Akihiko, Noro, Rintaro, Seike, Masahiro

“…Background Amrubicin (AMR) is one of the most active agents for small-cell lung cancer (SCLC). However, hematologic toxicity and infection at a commonly used…”
Get full text

Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial-mesenchymal transition is critical in conquering ALK-positive lung cancer by Nakamichi, Shinji, Seike, Masahiro, Miyanaga, Akihiko, Chiba, Mika, Zou, Fenfei, Takahashi, Akiko, Ishikawa, Arimi, Kunugi, Shinobu, Noro, Rintaro, Kubota, Kaoru, Gemma, Akihiko

“…Anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK-TKIs) induce a dramatic response in non-small cell lung cancer (NSCLC) patients with the fusion…”
Get full text

Prognostic significance of ABCB1 in stage I lung adenocarcinoma by Zou, Fenfei, Seike, Masahiro, Noro, Rintaro, Kunugi, Shinobu, Kubota, Kaoru, Gemma, Akihiko

“…Cancer stem cell (CSC) properties have been recently proposed to explain tumor carcinogenesis and multidrug resistance in several human cancers, including…”
Get full text

Significance of osteopontin in the sensitivity of malignant pleural mesothelioma to pemetrexed by TAKEUCHI, SUSUMU, SEIKE, MASAHIRO, NORO, RINTARO, SOENO, CHIE, SUGANO, TEPPEI, ZOU, FENFEI, UESAKA, HARUKA, NISHIJIMA, NOBUHIKO, MATSUMOTO, MASARU, MINEGISHI, YUJI, KUBOTA, KAORU, GEMMA, AKIHIKO

“…Pemetrexed (PEM) is currently recommended as one of the standard anticancer drugs for malignant pleural mesothelioma (MPM). However, the mechanism of the…”
Get full text

Prognostic Significance of NSCLC and Response to EGFR-TKIs of EGFR-Mutated NSCLC Based on PD-L1 Expression by Kobayashi, Kenichi, Seike, Masahiro, Zou, Fenfei, Noro, Rintaro, Chiba, Mika, Ishikawa, Arimi, Kunugi, Shinobu, Kubota, Kaoru, Gemma, Akihiko

“…Recent clinical trials have shown that immune checkpoint blockades that target either PD-1 or PD-L1 yield remarkable responses in a subgroup of patients with…”
Get full text

Abstract 3209: Polo-like kinase 1 as a new molecular target for small cell lung carcinoma by Rintaro, Noro, Seike, Masahiro, Zou, Fenfei, Miyanaga, Akihiko, Kubota, Kaoru, Gemma, Akihiko

Get full text

Abstract 5714: AXL and GAS6 Co-expression in lung adenocarcinoma as a prognostic classifier by Seike, Masahiro, Noro, Ritaro, Kim, Cheol-Hong, Zou, Fenfei, Kubota, Kaoru, Gemma, Akihiko

“…AXL, a receptor tyrosine kinase implicated in cell survival, proliferation, and migration, is also associated with acquired resistance to epidermal growth…”
Get full text

AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier by Seike, Masahiro, Kim, Cheol-Hong, Zou, Fenfei, Noro, Rintaro, Chiba, Mika, Ishikawa, Arimi, Κunugi, Shinobu, Kubota, Kaoru, Gemma, Akihiko

“…AXL, a receptor tyrosine kinase implicated in cell survival, proliferation, and migration, is also associated with acquired resistance to epidermal growth…”
Get full text

MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation by Noro, Rintaro, Seike, Masahiro, Zou, Fenfei, Soeno, Chie, Matsuda, Kuniko, Sugano, Teppei, Nishijima, Nobuhiko, Matsumoto, Masaru, Kitamura, Kazuhiro, Kosaihira, Seiji, Minegishi, Yuji, Yoshimura, Akinobu, Kubota, Kaoru, Gemma, Akihiko

“…Lung adenocarcinoma patients with EGFR gene mutations have shown a dramatic response to gefitinib. However, drug resistance eventually emerges which limits the…”
Get full text

AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifer by Seike, Masahiro, Kim, Cheol-Hong, Zou, Fenfei, Noro, Rintaro, Chiba, Mika, Ishikawa, Arimi, Kunugi, Shinobu, Kubota, Kaoru, Gemma, Akihiko

Get full text

Abstract 784: Significance of osteopontin in the sensitivity of malignant pleural mesothelioma to pemetrexed by Takeuchi, Susumu, Seike, Masahiro, Noro, Rintaro, Soeno, Chie, Sugano, Teppei, Zou, Fenfei, Matsumoto, Masaru, Miyanaga, Akihiko, Minegishi, Yuji, Kubota, Kaoru, Gemma, Akihiko

“…Background: Pemetrexed (PEM) is currently recommended as one of the standard anticancer drugs for malignant pleural mesothelioma (MPM). However, the mechanism…”
Get full text